NO-cGMP pathway increases the hyperpolarisation-activated current, I(f), and heart rate during adrenergic stimulation

N Herring1, L Rigg, D A Terrar

  • 1University Laboratory of Physiology, University of Oxford, Parks Road, OX1 3PT, Oxford, UK.

Cardiovascular Research
|December 12, 2001
PubMed

Insights

The nitric oxide (NO)-cGMP pathway transiently increases heart rate (HR) via the I(f) current during adrenergic stimulation. This effect is limited by phosphodiesterase 2 (PDE2) activity.

Area of Science:

  • Cardiovascular Physiology
  • Autonomic Nervous System Regulation
  • Cardiac Electrophysiology

Background:

  • The autonomic nervous system modulates heart rate (HR) through complex signaling pathways.
  • The role of the nitric oxide (NO)-cGMP pathway in cardiac pacemaking, particularly its interaction with the L-type calcium current (I(CaL)) and hyperpolarization-activated current (I(f)), remains controversial.
  • Understanding this pathway is crucial for comprehending cardiac autonomic control.

Purpose of the Study:

  • To investigate the hypothesis that the NO-cGMP pathway, following adrenergic stimulation, activates phosphodiesterase 2 (PDE2) to attenuate cAMP-dependent stimulation of I(f) and HR.
  • To elucidate the specific role of the NO-cGMP pathway in the autonomic modulation of sinoatrial node (SAN) function.

Main Methods:

  • Experiments were conducted on guinea pig SAN/atria preparations and isolated SAN cells in the presence of norepinephrine (NE).
  • The effects of the NO donor sodium nitroprusside (SNP) and 8Br-cGMP were assessed.
  • Pharmacological agents including guanylyl cyclase inhibitor (ODQ), I(f) blockers (CsCl, ZD7288), and PDE2 inhibitor (EHNA) were utilized.
  • RT-PCR was employed to confirm the presence of relevant phosphodiesterase (PDE) isoforms.

Main Results:

  • Contrary to the hypothesis, SNP and 8Br-cGMP caused a transient increase in HR.
  • This stimulatory effect on HR was dependent on the I(f) current, as it was abolished by I(f) blockers.
  • SNP also increased I(f) in isolated SAN cells, and inhibition of PDE2 augmented and prolonged the SNP-induced HR increase.
  • RT-PCR confirmed the expression of PDE2 and cGMP-inhibited PDE3 in SAN tissue.

Conclusions:

  • Activation of the NO-cGMP pathway during adrenergic stimulation leads to a transient, I(f)-dependent increase in HR, not a decrease.
  • The magnitude and duration of this stimulatory effect are regulated by PDE2 activity.
  • These findings clarify the role of the NO-cGMP pathway in cardiac pacemaking under adrenergic influence.
Abstract

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...